Retuta Esmeraldo MD is categorized under Internal Medicine Practitioners in Jersey City, NJ and active since 1981.
Retuta Esmeraldo MD was established in 1981, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Esmeraldo Retuta at the company’s single location by writing to 321 Old Bergen Road # 2, Jersey City, New Jersey NJ 07305 or by phoning (201) 435-2880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Retuta Esmeraldo MD |
| Contact Person: | Esmeraldo Retuta |
| Address: | 321 Old Bergen Road # 2, Jersey City, New Jersey 07305 |
| Phone Number: | (201) 435-2880 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Retuta Esmeraldo MD was started in 1981 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Esmeraldo Retuta for inquiries that concern Retuta Esmeraldo MD by calling the company number (201) 435-2880, as your correspondence is most welcome. Additionally, the physical location of the single location of Retuta Esmeraldo MD can be found at the coordinates 40.701,-74.0923 as well as the street address 321 Old Bergen Road # 2 in Jersey City, New Jersey 07305.
For its online presence, you may visit Retuta Esmeraldo MD’s website at and engage with its social media outlets through on Twitter and on Facebook.